World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
71
Citations
16544
World Ranking
2426
National Ranking
45

Erik Portelius publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Erik Portelius sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 233 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Erik Portelius D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Erik Portelius sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 71 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Erik Portelius is affiliated with Sahlgrenska University Hospital in Sweden and has contributed extensively to research in the field of medicine, with a particular focus on neurology and neurodegenerative diseases.

Portelius' work spans several subfields including physiology, molecular biology, neurology, psychiatry and mental health, as well as cellular and molecular neuroscience. Their research topics encompass:

  • Alzheimer's disease research and treatments
  • Dementia and cognitive impairment research
  • Amyloidosis: diagnosis, treatment, outcomes
  • S100 proteins and annexins
  • Down syndrome and intellectual disability research
  • Intracerebral and subarachnoid hemorrhage research
  • Neuroinflammation and neurodegeneration mechanisms

Recent publications by Portelius include:

  • Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain, 2020, Molecular Psychiatry
  • OUP accepted manuscript, 2020, Brain
  • Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease, 2021, Alzheimer's & Dementia Diagnosis Assessment & Disease Monitoring
  • Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics, 2021, Scientific Reports
  • Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases, 2020, Alzheimer's Research & Therapy

Portelius frequently publishes in journals such as:

  • Alzheimer's & Dementia
  • Alzheimer's Research & Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular Psychiatry
  • Brain

Throughout their career, Portelius has collaborated repeatedly with several co-authors, including:

  • Kaj Blennow
  • Henrik Zetterberg
  • Gunnar Brinkmalm
  • Eleni Gkanatsiou
  • Johan Gobom

Best Publications

  • CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

    Bob Olsson;Ronald Lautner;Ulf Andreasson;Annika Öhrfelt

  • Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression

    Henrik Zetterberg;Henrik Zetterberg;Tobias Skillbäck;Niklas Mattsson;John Q. Trojanowski

  • Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

    Vladimir Coric;Christopher H. van Dyck;Stephen Salloway;Niels Andreasen

  • Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease

    Erik Portelius;Nenad Bogdanovic;Mikael K. Gustavsson;Inga Volkmann

  • Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

    Hlin Kvartsberg;Flora H. Duits;Martin Ingelsson;Niels Andreasen

  • Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.

    Erik Portelius;Ann Westman-Brinkmalm;Henrik Zetterberg;Kaj Blennow

  • Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid

    Adnan Halim;Gunnar Brinkmalm;Ulla Rüetschi;Ann Westman-Brinkmalm

  • Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

    Niklas Mattsson;Philip S Insel;Philip S Insel;Sebastian Palmqvist;Erik Portelius

  • Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease

    Erik Portelius;Henrik Zetterberg;Henrik Zetterberg;Tobias Skillbäck;Ulrika Törnqvist

  • Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

    Maria Bjerke;Erik Portelius;Lennart Minthon;Anders Wallin

  • Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.

    Jere E. Meredith;Sethu Sankaranarayanan;Valerie Guss;Anthony J. Lanzetti

  • Increased CSF neurogranin concentration is specific to Alzheimer disease.

    Henrietta Wellington;Ross W. Paterson;Erik Portelius;Ulrika Törnqvist

  • Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

    Bob Olsson;Bob Olsson;Erik Portelius;Erik Portelius;Nicholas C. Cullen;Nicholas C. Cullen;Åsa Sandelius

  • A novel pathway for amyloid precursor protein processing.

    Erik Portelius;Eric Price;Gunnar Brinkmalm;Mark Stiteler

  • Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease

    Jay Rasmussen;Jay Rasmussen;Jasmin Mahler;Natalie Beschorner;Stephan A. Kaeser;Stephan A. Kaeser

  • Pathways to Alzheimer's disease

    J. Hardy;N. Bogdanovic;B. Winblad;E. Portelius

  • Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry.

    Erik Portelius;Ai Jun Tran;Ulf Andreasson;Rita Persson

  • APP metabolism regulates tau proteostasis in human cerebral cortex neurons

    Steven James Moore;Lewis D Evans;Therése Andersson;Erik Portelius

  • C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

    Ann De Vos;Dirk Jacobs;Hanne Struyfs;Erik Fransen

  • Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology

    Åsa Sandelius;Erik Portelius;Åsa Källén;Henrik Zetterberg

  • Mass Spectrometry–Based Candidate Reference Measurement Procedure for Quantification of Amyloid-β in Cerebrospinal Fluid

    Andreas Leinenbach;Josef Pannee;Thomas Dülffer;Andreas Huber

  • An Alzheimer's disease-specific β-amyloid fragment signature in cerebrospinal fluid

    Erik Portelius;Henrik Zetterberg;Ulf Andreasson;Gunnar Brinkmalm

Frequent Co-Authors

Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Kaj Blennow
Kaj Blennow University of Gothenburg
Ulf Andreasson
Ulf Andreasson University of Gothenburg
Kina Höglund
Kina Höglund Sahlgrenska University Hospital
Niklas Mattsson
Niklas Mattsson Lund University
Oskar Hansson
Oskar Hansson Lund University
Leslie M. Shaw
Leslie M. Shaw University of Pennsylvania
Maria Bjerke
Maria Bjerke University of Antwerp
Nick C. Fox
Nick C. Fox University College London
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a neuroscience career often leads students to consider related fields and flexible degree options. Online degrees in related disciplines such as psychology, social work, and behavioral analysis provide pathways for those interested in the brain and human behavior. Many students look for the most affordable online msw programs to minimize student debt while advancing their expertise in social work and mental health settings.

If you're interested in therapy or behavioral interventions, bcba online masters programs offer a way to specialize in applied behavior analysis. For those looking for a quicker route, there are accelerated msw programs without bsw, helping students earn a master's degree faster even without prior social work experience.

For a more foundational approach, some learners opt for a 2-year psychology degree online. These programs are designed for flexibility and rapid entry into the workforce, often providing stepping stones to graduate-level neuroscience or therapy programs. Choosing the right online degree can open up diverse roles in research, healthcare, and counseling.

Best Scientists Citing Erik Portelius

Trending Scientists

Recently Published Articles